Literature DB >> 11886873

Characterization of neuropilin-1 structural features that confer binding to semaphorin 3A and vascular endothelial growth factor 165.

Chenghua Gu1, Brian J Limberg, G Brian Whitaker, Ben Perman, Daniel J Leahy, Jan S Rosenbaum, David D Ginty, Alex L Kolodkin.   

Abstract

Neuropilin-1 (Npn-1) is a receptor for both semaphorin 3A (Sema3A) and vascular endothelial growth factor 165 (VEGF(165)). To understand the role Npn-1 plays as a receptor for these structurally and functionally unrelated ligands, we set out to identify structural features of Npn-1 that confer binding to Sema3A or VEGF(165). We constructed Npn-1 variants containing deletions within the "a" and "b" domains of Npn-1. More than 16 variants were expressed in COS-1 cells and tested for alkaline phosphatase-Sema3A as well as alkaline phosphatase-VEGF(165) binding. Our results indicate that each of the two Npn-1 CUB domains and the amino-terminal coagulation factor V/VIII domain (CF V/VIII) are essential for Sema3A binding, but only the amino-terminal Npn-1 CF V/VIII domain is required for binding to VEGF(165). Guided by the structure of the bovine spermadhesin CUB domain, point mutants targeting defined surfaces of the Npn-1 a1 CUB domain were generated and tested for Sema3A and VEGF(165) binding. One Npn-1 variant, Npn-1(2ABC), exhibits complete loss of Sema3A binding while retaining normal VEGF(165) binding. Moreover, co-immunoprecipitation experiments show that Npn-1(2ABC) can form a signaling complex with the VEGF(165) signaling receptor KDR/VEGFR-2. These results establish the identity of contact sites between Npn-1 and its semaphorin ligands, and they provide a foundation for understanding how Npn-1 functions as a receptor for distinct classes of ligands in vivo.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11886873     DOI: 10.1074/jbc.M201681200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  95 in total

Review 1.  Neuropilin Functions as an Essential Cell Surface Receptor.

Authors:  Hou-Fu Guo; Craig W Vander Kooi
Journal:  J Biol Chem       Date:  2015-10-08       Impact factor: 5.157

2.  Structural basis for selective vascular endothelial growth factor-A (VEGF-A) binding to neuropilin-1.

Authors:  Matthew W Parker; Ping Xu; Xiaobo Li; Craig W Vander Kooi
Journal:  J Biol Chem       Date:  2012-02-07       Impact factor: 5.157

Review 3.  Navigating breast cancer: axon guidance molecules as breast cancer tumor suppressors and oncogenes.

Authors:  Gwyndolen C Harburg; Lindsay Hinck
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-08-05       Impact factor: 2.673

4.  Semaphorin 3E-Plexin-D1 signaling regulates VEGF function in developmental angiogenesis via a feedback mechanism.

Authors:  Jiha Kim; Won-Jong Oh; Nicholas Gaiano; Yutaka Yoshida; Chenghua Gu
Journal:  Genes Dev       Date:  2011-07-01       Impact factor: 11.361

5.  Structural studies of neuropilin/antibody complexes provide insights into semaphorin and VEGF binding.

Authors:  Brent A Appleton; Ping Wu; Janice Maloney; JianPing Yin; Wei-Ching Liang; Scott Stawicki; Kyle Mortara; Krista K Bowman; J Michael Elliott; William Desmarais; J Fernando Bazan; Anil Bagri; Marc Tessier-Lavigne; Alexander W Koch; Yan Wu; Ryan J Watts; Christian Wiesmann
Journal:  EMBO J       Date:  2007-11-08       Impact factor: 11.598

6.  Inhibition of Semaphorin3A Promotes Ocular Dominance Plasticity in the Adult Rat Visual Cortex.

Authors:  Elena Maria Boggio; Erich M Ehlert; Leonardo Lupori; Elizabeth B Moloney; Fred De Winter; Craig W Vander Kooi; Laura Baroncelli; Vasilis Mecollari; Bas Blits; James W Fawcett; Joost Verhaagen; Tommaso Pizzorusso
Journal:  Mol Neurobiol       Date:  2019-01-31       Impact factor: 5.590

Review 7.  The role of semaphorins and their receptors in vascular development and cancer.

Authors:  Chenghua Gu; Enrico Giraudo
Journal:  Exp Cell Res       Date:  2013-02-17       Impact factor: 3.905

8.  Sema3A maintains corneal avascularity during development by inhibiting Vegf induced angioblast migration.

Authors:  Chelsey C McKenna; Ana F Ojeda; James Spurlin; Sam Kwiatkowski; Peter Y Lwigale
Journal:  Dev Biol       Date:  2014-05-06       Impact factor: 3.582

9.  Neuropilin-1 antagonism in human carcinoma cells inhibits migration and enhances chemosensitivity.

Authors:  H Jia; L Cheng; M Tickner; A Bagherzadeh; D Selwood; I Zachary
Journal:  Br J Cancer       Date:  2010-01-19       Impact factor: 7.640

10.  Full-length sequence of mouse acupuncture-induced 1-L (aig1l) gene including its transcriptional start site.

Authors:  Mika Ohta; Aki Sugano; Shuji Goto; Surini Yusoff; Yushi Hirota; Kotaro Funakoshi; Kenji Miura; Eiichi Maeda; Nobuo Takaoka; Nobuko Sato; Hiroshi Ishizuka; Naoki Arizono; Hisahide Nishio; Yutaka Takaoka
Journal:  Evid Based Complement Alternat Med       Date:  2011-02-17       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.